Kruse Bo

CIK 00017529401 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001752940

Recent Transactions

38 trades

Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2024-05-31$12.07/sh−31,371→ 210,877 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Common Stock
2024-05-31$2.00/sh+31,371→ 242,248 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-05-31−31,371→ 240,000 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2024-05-30$12.03/sh−28,629→ 210,877 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Common Stock
2024-05-30$2.00/sh+28,629→ 239,506 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-05-30−28,629→ 271,371 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-01-18+108,900→ 108,900 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2024-01-18+18,100→ 210,877 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2023-01-17+11,700→ 192,777 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-01-17+70,100→ 70,100 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2022-04-26+75,000→ 75,000 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2022-02-22$7.85/sh−4,000→ 181,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2022-02-04$7.97/sh−4,000→ 185,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2022-01-24$9.84/sh−4,000→ 189,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2022-01-04$17.12/sh−4,000→ 193,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-12-22$16.36/sh−4,000→ 197,077 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2021-12-14+85,000→ 85,000 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-12-06$16.35/sh−4,000→ 201,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-11-22$18.09/sh−4,000→ 205,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-11-04$27.54/sh−4,000→ 209,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-10-22$25.94/sh−4,000→ 213,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-10-04$28.78/sh−4,000→ 217,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-09-22$30.82/sh−4,000→ 221,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-09-07$32.03/sh−4,000→ 225,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-08-23$28.60/sh−4,000→ 229,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-08-04$33.72/sh−4,000→ 233,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-07-22$34.50/sh−4,000→ 237,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-07-06$34.15/sh−4,000→ 241,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-06-22$36.17/sh−4,000→ 245,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-06-04$33.48/sh−4,000→ 249,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-05-24$35.61/sh−4,000→ 253,077 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2020-12-15+72,350→ 72,350 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2020-05-14$36.03/sh−37,847→ 0 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2020-05-14$36.03/sh−28,199→ 257,077 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2020-05-13$37.86/sh−14,724→ 285,276 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2020-05-13$37.88/sh−19,230→ 37,847 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2020-01-07+130,000→ 130,000 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2018-12-11+107,500→ 107,500 total

Companies

Y-mAbs Therapeutics, Inc.
Director, EVP, CFO, Secy & Treas.

Recent Filings

Address

C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, 33RD FLOOR

NEW YORK, NY, 10169

View on SEC.gov